Baxter International (BAX) Stock Forecast & Price Target

Compare

1,475 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BAX Analyst Ratings

Hold

3 Buy

5 Hold

1 Sell

Based on 9 analysts giving stock ratings to

Baxter

International

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BAX Stock 12 Month Forecast

Average Price Target

$35.75

▲(18.57%Upside)

Based on 9 Wall Street analysts offering 12 month price targets for Baxter International in the last 3 months. The average price target is $35.75 with a high forecast of $41.00 and a low forecast of $28.00. The average price target represents a 18.57% change from the last price of $30.15.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"27":"$27","31":"$31","35":"$35","39":"$39","43":"$43"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":41,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$41.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$35.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$28.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[27,31,35,39,43],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Jan<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.5,31.307692307692307,32.11538461538461,32.92307692307692,33.73076923076923,34.53846153846154,35.34615384615385,36.15384615384615,36.96153846153846,37.76923076923077,38.57692307692308,39.38461538461539,40.19230769230769,{"y":41,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.5,30.903846153846153,31.307692307692307,31.71153846153846,32.11538461538461,32.51923076923077,32.92307692307692,33.32692307692308,33.73076923076923,34.13461538461539,34.53846153846154,34.94230769230769,35.34615384615385,{"y":35.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.5,30.307692307692307,30.115384615384617,29.923076923076923,29.73076923076923,29.53846153846154,29.346153846153847,29.153846153846153,28.96153846153846,28.76923076923077,28.576923076923077,28.384615384615383,28.192307692307693,{"y":28,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":42.18,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.07,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.31,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.3,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.18,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.36,"date":1725148800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":36.34,"date":1727740800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":35.32,"date":1730419200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":33.2,"date":1733011200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":28.86,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.22,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.32,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.5,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$41.00

Average Price Target$35.75

Lowest Price Target$28.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$31

Hold

2.82%

Upside

Reiterated

05/22/25

The overall score reflects a mixed outlook for Baxter International. The earnings call provided a positive view with strong segment performance and exceeded guidance, significantly boosting the score. However, financial performance challenges, bearish technical indicators, and valuation concerns due to a negative P/E ratio weigh heavily. The stock's potential is contingent on strategic improvements in profitability and operational efficiency.

Joanne WuenschCiti

Citi

$34

Hold

12.77%

Upside

Reiterated

05/22/25

Baxter International (BAX) Gets a Hold from Citi

Steven SilverArgus Research

Argus Research

$40

Buy

32.67%

Upside

Reiterated

05/05/25

Analysts Offer Insights on Healthcare Companies: Baxter International (NYSE: BAX) and Vera Therapeutics (NASDAQ: VERA)

Patrick WoodMorgan Stanley

Morgan Stanley

$30→$28

Sell

-7.13%

Downside

Reiterated

05/05/25

Baxter International (BAX) Receives a Sell from Morgan Stanley

Matthew TaylorJefferies

Jefferies

―

Hold

―

Reiterated

05/02/25

Analysts Offer Insights on Healthcare Companies: GeoVax Labs (NASDAQ: GOVX) and Baxter International (NYSE: BAX)

Robbie MarcusJ.P. Morgan

J.P. Morgan

$36→$34

Hold

12.77%

Upside

Reiterated

05/02/25

J.P. Morgan Sticks to Their Hold Rating for Baxter International (BAX)

Rick WiseStifel Nicolaus

Stifel Nicolaus

$36

Buy

19.40%

Upside

Reiterated

05/02/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Larry BiegelsenWells Fargo

Wells Fargo

$33

Hold

9.45%

Upside

Reiterated

05/01/25

Baxter International: Balancing Growth Potential and Tariff Challenges with a Hold Rating

Josh JenningsTD Cowen

TD Cowen

$40

Hold

32.67%

Upside

Reiterated

05/01/25

Balanced Outlook on Baxter International: Strong Performance with Margin Concerns

Matt MiksicBarclays

Barclays

$39→$41

Buy

35.99%

Upside

Reiterated

03/07/25

Baxter International (BAX) Gets a Buy from Barclays

Chris HusseyGoldman Sachs

Goldman Sachs

―

Buy

―

Initiated

02/26/25

Baxter International (BAX) was downgraded to a Hold Rating at Goldman SachsUS February 26, 2025 26 February 2025 | 8:42AM EST Sachs' US morning call today, we relaunch coverage of Baxter (BAX), check in on Alnylam (ALNY) and Intuit (INTU), and downgrade Sempra (SRE) to Neutral. The full list of speakers and topics are listed within.

Unknown AnalystUBS

Not Ranked

UBS

$32.5→$35

Hold

16.09%

Upside

Reiterated

02/24/25

Baxter International (BAX) PT Raised to $35 at UBSUBS analyst Danielle Antalffy raised the price target on Baxter International (NYSE: BAX) to $35.00 (from $32.50) while maintaining a Neutral rating.

Vijay KumarEvercore ISI

Evercore ISI

$42→$44

Buy

45.94%

Upside

Reiterated

02/21/25

Evercore ISI Sticks to Their Buy Rating for Baxter International (BAX)

Travis SteedBank of America Securities

Bank of America Securities

$40

Hold

32.67%

Upside

Reiterated

02/20/25

Baxter International's 2025 Outlook: Hold Rating Amid Growth Potential and Leadership Transition

Unknown AnalystCFRA

Not Ranked

CFRA

$30

Sell

-0.50%

Downside

Downgraded

11/11/24

CFRA downgrades Baxter International (BAX) to Sell (nidday)CFRA downgraded Baxter International (NYSE: BAX) from Hold to Sell with a price target of $30.00.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$31

Hold

2.82%

Upside

Reiterated

05/22/25

Joanne WuenschCiti

Citi

$34

Hold

12.77%

Upside

Reiterated

05/22/25

Baxter International (BAX) Gets a Hold from Citi

Steven SilverArgus Research

Argus Research

$40

Buy

32.67%

Upside

Reiterated

05/05/25

Analysts Offer Insights on Healthcare Companies: Baxter International (NYSE: BAX) and Vera Therapeutics (NASDAQ: VERA)

Patrick WoodMorgan Stanley

Morgan Stanley

$30→$28

Sell

-7.13%

Downside

Reiterated

05/05/25

Baxter International (BAX) Receives a Sell from Morgan Stanley

Matthew TaylorJefferies

Jefferies

―

Hold

―

Reiterated

05/02/25

Analysts Offer Insights on Healthcare Companies: GeoVax Labs (NASDAQ: GOVX) and Baxter International (NYSE: BAX)

Robbie MarcusJ.P. Morgan

J.P. Morgan

$36→$34

Hold

12.77%

Upside

Reiterated

05/02/25

J.P. Morgan Sticks to Their Hold Rating for Baxter International (BAX)

Rick WiseStifel Nicolaus

Stifel Nicolaus

$36

Buy

19.40%

Upside

Reiterated

05/02/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Larry BiegelsenWells Fargo

Wells Fargo

$33

Hold

9.45%

Upside

Reiterated

05/01/25

Baxter International: Balancing Growth Potential and Tariff Challenges with a Hold Rating

Josh JenningsTD Cowen

TD Cowen

$40

Hold

32.67%

Upside

Reiterated

05/01/25

Balanced Outlook on Baxter International: Strong Performance with Margin Concerns

Matt MiksicBarclays

Barclays

$39→$41

Buy

35.99%

Upside

Reiterated

03/07/25

Baxter International (BAX) Gets a Buy from Barclays

Chris HusseyGoldman Sachs

Goldman Sachs

―

Buy

―

Initiated

02/26/25

Unknown AnalystUBS

Not Ranked

UBS

$32.5→$35

Hold

16.09%

Upside

Reiterated

02/24/25

Baxter International (BAX) PT Raised to $35 at UBSUBS analyst Danielle Antalffy raised the price target on Baxter International (NYSE: BAX) to $35.00 (from $32.50) while maintaining a Neutral rating.

Vijay KumarEvercore ISI

Evercore ISI

$42→$44

Buy

45.94%

Upside

Reiterated

02/21/25

Evercore ISI Sticks to Their Buy Rating for Baxter International (BAX)

Travis SteedBank of America Securities

Bank of America Securities

$40

Hold

32.67%

Upside

Reiterated

02/20/25

Baxter International's 2025 Outlook: Hold Rating Amid Growth Potential and Leadership Transition

Unknown AnalystCFRA

Not Ranked

CFRA

$30

Sell

-0.50%

Downside

Downgraded

11/11/24

CFRA downgrades Baxter International (BAX) to Sell (nidday)CFRA downgraded Baxter International (NYSE: BAX) from Hold to Sell with a price target of $30.00.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Baxter International

1 Month

xxx

Success Rate

11/22 ratings generated profit

Average Return

-1.48%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -1.48% per trade.

3 Months

xxx

Success Rate

6/14 ratings generated profit

Average Return

-1.06%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -1.06% per trade.

1 Year

Vijay KumarEvercore ISI

Success Rate

6/14 ratings generated profit

Average Return

-2.94%

reiterated a buy rating 4 months ago

Copying Vijay Kumar's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -2.94% per trade.

2 Years

xxx

Success Rate

5/14 ratings generated profit

Average Return

-4.56%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 35.71% of your transactions generating a profit, with an average return of -4.56% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BAX Analyst Recommendation Trends

Rating

Dec 24

Jan 25

Feb 25

Mar 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BAX has received 8 Buy Ratings, 11 Hold Ratings, and 2 Sell Ratings. BAX average Analyst price target in the past 3 months is 35.75.

Each month's total comprises the sum of three months' worth of ratings.

BAX Financial Forecast

BAX Earnings Forecast

Next quarter’s earnings estimate for BAX is $0.61 with a range of $0.59 to $0.63. The previous quarter’s EPS was $0.55. BAX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year BAX has Outperformed its overall industry.

BAX Sales Forecast

Next quarter’s sales forecast for BAX is $2.82B with a range of $2.80B to $2.86B. The previous quarter’s sales results were $2.63B. BAX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year BAX has Outperformed its overall industry.

BAX Stock Forecast FAQ

What is BAX’s average 12-month price target, according to analysts?

Based on analyst ratings, Baxter International’s 12-month average price target is 35.75.

What is BAX’s upside potential, based on the analysts’ average price target?

Baxter International has 18.57% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is BAX a Buy, Sell or Hold?

Baxter International has a consensus rating of Hold which is based on 3 buy ratings, 5 hold ratings and 1 sell ratings.

What is Baxter International’s price target?

The average price target for Baxter International is 35.75. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $41.00 ,the lowest forecast is $28.00. The average price target represents 18.57% Increase from the current price of $30.15.

What do analysts say about Baxter International?

Baxter International’s analyst rating consensus is a Hold. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of BAX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Baxter International (BAX) Stock Forecast & Price Target

BAX Analyst Ratings

BAX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Baxter International

BAX Analyst Recommendation Trends

BAX Financial Forecast

BAX Earnings Forecast

BAX Sales Forecast

BAX Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts